AngioDynamics (ANGO) delivered earnings and revenue surprises of 63.64% and 2.36%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?

Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief ...

AngioDynamics Inc. ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter. On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents.

Northern elders have broken their silence on rumours of an internal rift. The elders spoke via a statement issued by a key ...

AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...

COLONIE — Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding ...

Northern Elders Forum (NEF) has announced the appointment of Professor Abubakar Jika Jiddere as its new spokesperson. The ...

ABUJA – THE Northern Elders Forum, NEF, Wednesday, appointed a new Spokesperson, Prof Abubakar Jika Jiddere.

In trading on Wednesday, utilities shares tumbled by 1%. U.S. initial jobless claims fell by 10,000 to 201,000 in the week ending Jan. 4, recording the lowest level in eleven months and versus market ...

AngioDynamics narrowed its loss in its latest quarter even as sales declined from a year earlier. The medical-device maker narrowed its loss to $10.7 million, or 26 cents a share, for the second ...